Karachi, In a recent board meeting held on September 27, 2023, at Karachi, IBL HealthCare Limited has announced its recommendations for various entitlements for its shareholders. The key recommendations include:

(i) Cash Dividend: The Board has recommended a final Cash Dividend for the year ending on an unspecified date at Rs. NIL per share, which amounts to NIL%. This Cash Dividend is in addition to any Interim Dividend(s) that have already been paid at Rs. NIL per share, also at NIL%.

(ii) Bonus Shares: The Board has proposed the issuance of Bonus Shares in the ratio of 20 shares for every 100 shares held, equivalent to 20%. This recommendation comes in addition to the Interim Bonus Shares already issued at a rate of 0%.

(iii) Right Shares: The Board has recommended issuing NIL% Right Shares at par, at a discount, or at a premium of Rs. NIL per share. These shares will be offered in proportion to NIL share(s) for every NIL share(s). The entitlement of right shares, whether declared simultaneously, will be subject to specific conditions related to Bonus Shares as declared above.

(iv) Any Other Entitlement/Corporate Action: None

(v) Any Other Price-Sensitive Information: None

The financial results for IBL HealthCare Limited for the year ending June 30, 2023, have also been disclosed, including a Profit & Loss Account and earnings per share. No qualifications or observations by auditors were mentioned in the announcement.

IBL HealthCare Limited's Annual General Meeting is scheduled to be held on October 27, 2023, in Karachi. The entitlements recommended by the Board will be distributed to shareholders whose names appear in the Register of Members on October 21, 2023. To facilitate this process, the Share Transfer Books of the Company will remain closed from October 21, 2023, to October 27, 2023, inclusive.